Voltage-dependent L-type calcium channel subunit alpha-1C — Drug Target

All drugs that target Voltage-dependent L-type calcium channel subunit alpha-1C — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Calcium Channel Blocker · Dihydropyridine Calcium Channel Blocker [EPC] · endralazine

Marketed (5)

• Isoptin · Calcium Channel Blocker · Cardiovascular
• Procardia · Pfizer · Dihydropyridine Calcium Channel Blocker [EPC] · Metabolic
• Sular · Azurity · Dihydropyridine Calcium Channel Blocker [EPC] · Cardiovascular
  Sular works by blocking calcium channels in blood vessel walls, which relaxes the blood vessels and lowers blood pressure.
• Cleviprex · Chiesi · Dihydropyridine Calcium Channel Blocker [EPC] · Cardiovascular
  Cleviprex works by blocking calcium channels in blood vessel walls, causing them to relax and lower blood pressure.
• Procardia · Pfizer · Dihydropyridine Calcium Channel Blocker [EPC] · Metabolic

Phase 2 pipeline (1)

• Miretilan · endralazine · Cardiovascular
  Miretilan works by blocking calcium channels in blood vessels, which helps to lower blood pressure.